Table 2.
Variables | CrAg+ (n = 9): n (%) | CrAg− (n = 258): n (%) | p‐value* | |
---|---|---|---|---|
Gender | ||||
Female | 1 (0.7) | 136 (99.8) | 1 | |
Male | 8 (6.2) | 122 (93.8) | 0.017* | |
Age (Years) | ||||
18–27 | 1 (3.1) | 31 (96.9) | ||
28–37 | 4 (4.0) | 95 (96.0) | ||
38–47 | 4 (4.4) | 86 (95.6) | NA | |
48–57 | 0 (0.0) | 29 (100.0) | ||
58–67 | 0 (0.0) | 15 (100.0) | ||
68–75 | 0 (0.0) | 2 (100.0) | ||
Residence | ||||
Urban | 4 (1.8) | 218 (98.2) | 1 | |
Rural | 5 (11.1) | 40 (88.9) | 0.008* | |
Patients | ||||
Out patients | 1 (0.4) | 230 (99.6) | 1 | |
Inpatient | 8 (22.2) | 28 (77.8) | 0.001* | |
CD4 count(cells/µl) | ||||
≥100 | 1 (0.6) | 159 (99.4) | 1 | |
<100 | 8 (7.5) | 99 (92.5) | 0.003* | |
ART status | ||||
ART naive | 6 (4.7) | 121 (95.3) | 1 | |
On ART | 3 (2.1) | 137 (97.9) | 0.317 |
CrAg+: positive for cryptococcal antigenemia; CrAg−: negative for cryptococcal antigenemia.
Fisher's exact test.